ID   TEC_HUMAN               Reviewed;         631 AA.
AC   P42680; B7ZKZ6; Q3MIS5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   11-SEP-2007, sequence version 2.
DT   10-MAY-2017, entry version 174.
DE   RecName: Full=Tyrosine-protein kinase Tec;
DE            EC=2.7.10.2;
GN   Name=TEC; Synonyms=PSCTK4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   PubMed=7934162;
RA   Sato K., Mano H., Ariyama T., Inazawa J., Yazaki Y., Hirai H.;
RT   "Molecular cloning and analysis of the human Tec protein-tyrosine
RT   kinase.";
RL   Leukemia 8:1663-1672(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 203-206, AND PHOSPHORYLATION AT TYR-206.
RX   PubMed=12573241; DOI=10.1016/S1570-9639(02)00524-1;
RA   Nore B.F., Mattsson P.T., Antonsson P., Backesjo C.-M., Westlund A.,
RA   Lennartsson J., Hansson H., Low P., Ronnstrand L., Smith C.I.E.;
RT   "Identification of phosphorylation sites within the SH3 domains of Tec
RT   family tyrosine kinases.";
RL   Biochim. Biophys. Acta 1645:123-132(2003).
RN   [5]
RP   PHOSPHORYLATION, INTERACTION WITH KIT, AND ENZYME REGULATION.
RX   PubMed=7526158; DOI=10.1128/MCB.14.12.8432;
RA   Tang B., Mano H., Yi T., Ihle J.N.;
RT   "Tec kinase associates with c-kit and is tyrosine phosphorylated and
RT   activated following stem cell factor binding.";
RL   Mol. Cell. Biol. 14:8432-8437(1994).
RN   [6]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=9299487; DOI=10.1006/bbrc.1997.7269;
RA   Laffargue M., Monnereau L., Tuech J., Ragab A., Ragab-Thomas J.,
RA   Payrastre B., Raynal P., Chap H.;
RT   "Integrin-dependent tyrosine phosphorylation and cytoskeletal
RT   translocation of Tec in thrombin-activated platelets.";
RL   Biochem. Biophys. Res. Commun. 238:247-251(1997).
RN   [7]
RP   ENZYME REGULATION.
RX   PubMed=9341160; DOI=10.1074/jbc.272.43.27178;
RA   Ohya K., Kajigaya S., Yamashita Y., Miyazato A., Hatake K., Miura Y.,
RA   Ikeda U., Shimada K., Ozawa K., Mano H.;
RT   "SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine
RT   kinase.";
RL   J. Biol. Chem. 272:27178-27182(1997).
RN   [8]
RP   INTERACTION WITH GRB10, AND FUNCTION IN PHOSPHORYLATION OF GRB10.
RX   PubMed=9753425; DOI=10.1046/j.1365-2443.1998.00201.x;
RA   Mano H., Ohya K., Miyazato A., Yamashita Y., Ogawa W., Inazawa J.,
RA   Ikeda U., Shimada K., Hatake K., Kasuga M., Ozawa K., Kajigaya S.;
RT   "Grb10/GrbIR as an in vivo substrate of Tec tyrosine kinase.";
RL   Genes Cells 3:431-441(1998).
RN   [9]
RP   PHOSPHORYLATION, ENZYME REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=9652744; DOI=10.1038/sj.onc.1201799;
RA   Hamazaki Y., Kojima H., Mano H., Nagata Y., Todokoro K., Abe T.,
RA   Nagasawa T.;
RT   "Tec is involved in G protein-coupled receptor- and integrin-mediated
RT   signalings in human blood platelets.";
RL   Oncogene 16:2773-2779(1998).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF STAP1, AND ENZYME REGULATION.
RX   PubMed=10518561; DOI=10.1073/pnas.96.21.11976;
RA   Ohya K., Kajigaya S., Kitanaka A., Yoshida K., Miyazato A.,
RA   Yamashita Y., Yamanaka T., Ikeda U., Shimada K., Ozawa K., Mano H.;
RT   "Molecular cloning of a docking protein, BRDG1, that acts downstream
RT   of the Tec tyrosine kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:11976-11981(1999).
RN   [11]
RP   INTERACTION WITH INPP5D AND INPPL1.
RX   PubMed=15492005; DOI=10.1074/jbc.M408141200;
RA   Tomlinson M.G., Heath V.L., Turck C.W., Watson S.P., Weiss A.;
RT   "SHIP family inositol phosphatases interact with and negatively
RT   regulate the Tec tyrosine kinase.";
RL   J. Biol. Chem. 279:55089-55096(2004).
RN   [12]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL
RT   (CD178) by phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-206 AND TYR-228, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-519, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=19883687; DOI=10.1016/j.imlet.2009.10.009;
RA   Susaki K., Kitanaka A., Dobashi H., Kubota Y., Kittaka K., Kameda T.,
RA   Yamaoka G., Mano H., Mihara K., Ishida T.;
RT   "Tec protein tyrosine kinase inhibits CD25 expression in human T-
RT   lymphocyte.";
RL   Immunol. Lett. 127:135-142(2010).
RN   [16]
RP   FUNCTION IN PHOSPHORYLATION OF FGF2, AND INTERACTION WITH FGF2.
RX   PubMed=20230531; DOI=10.1111/j.1600-0854.2010.01059.x;
RA   Ebert A.D., Laussmann M., Wegehingel S., Kaderali L., Erfle H.,
RA   Reichert J., Lechner J., Beer H.D., Pepperkok R., Nickel W.;
RT   "Tec-kinase-mediated phosphorylation of fibroblast growth factor 2 is
RT   essential for unconventional secretion.";
RL   Traffic 11:813-826(2010).
RN   [17]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-44 AND LYS-563.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Non-receptor tyrosine kinase that contributes to
CC       signaling from many receptors and participates as a signal
CC       transducer in multiple downstream pathways, including regulation
CC       of the actin cytoskeleton. Plays a redundant role to ITK in
CC       regulation of the adaptive immune response. Regulates the
CC       development, function and differentiation of conventional T-cells
CC       and nonconventional NKT-cells. Required for TCR-dependent IL2 gene
CC       induction. Phosphorylates DOK1, one CD28-specific substrate, and
CC       contributes to CD28-signaling. Mediates signals that negatively
CC       regulate IL2RA expression induced by TCR cross-linking. Plays a
CC       redundant role to BTK in BCR-signaling for B-cell development and
CC       activation, especially by phosphorylating STAP1, a BCR-signaling
CC       protein. Required in mast cells for efficient cytokine production.
CC       Involved in both growth and differentiation mechanisms of myeloid
CC       cells through activation by the granulocyte colony-stimulating
CC       factor CSF3, a critical cytokine to promoting the growth,
CC       differentiation, and functional activation of myeloid cells.
CC       Participates in platelet signaling downstream of integrin
CC       activation. Cooperates with JAK2 through reciprocal
CC       phosphorylation to mediate cytokine-driven activation of FOS
CC       transcription. GRB10, a negative modifier of the FOS activation
CC       pathway, is another substrate of TEC. TEC is involved in G
CC       protein-coupled receptor- and integrin-mediated signalings in
CC       blood platelets. Plays a role in hepatocyte proliferation and
CC       liver regeneration and is involved in HGF-induced ERK signaling
CC       pathway. TEC regulates also FGF2 unconventional secretion
CC       (endoplasmic reticulum (ER)/Golgi-independent mechanism) under
CC       various physiological conditions through phosphorylation of FGF2
CC       'Tyr-215'. May also be involved in the regulation of osteoclast
CC       differentiation. {ECO:0000269|PubMed:10518561,
CC       ECO:0000269|PubMed:19883687, ECO:0000269|PubMed:20230531,
CC       ECO:0000269|PubMed:9753425}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- ENZYME REGULATION: Activated by tyrosine phosphorylation by a wide
CC       range of cytokine stimulations. When T-cells or B-cells receptors
CC       are activated, a series of phosphorylation leads to the
CC       recruitment of TEC to the cell membrane, where it is
CC       phosphorylated at Tyr-519. Also activated in response to SCF.
CC       Integrin engagement induces tyrosine phosphorylation of TEC in
CC       platelets. STAP1 participates in a positive feedback loop by
CC       increasing the activity of TEC. SOCS1 is an inhibitor of TEC
CC       kinase activity. {ECO:0000269|PubMed:10518561,
CC       ECO:0000269|PubMed:7526158, ECO:0000269|PubMed:9341160,
CC       ECO:0000269|PubMed:9652744}.
CC   -!- SUBUNIT: Interacts with INPP5D/SHIP1 and INPPL1/SHIP2. Interacts
CC       with CD28, FASLG, FGF2, GRB10, LYN and KIT. Interacts with VAV1
CC       and JAK2 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q13480:GAB1; NbExp=2; IntAct=EBI-1383480, EBI-517684;
CC       P08581:MET; NbExp=2; IntAct=EBI-1383480, EBI-1039152;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane; Peripheral
CC       membrane protein. Cytoplasm, cytoskeleton. Note=Following B-cell
CC       or T-cell receptors activation by antigen, translocates to the
CC       plasma membrane through its PH domain. Thrombin and integrin
CC       engagement induces translocation of TEC to the cytoskeleton during
CC       platelet activation. In cardiac myocytes, assumes a diffuse
CC       intracellular localization under basal conditions but is recruited
CC       to striated structures upon various stimuli, including ATP (By
CC       similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in a wide range of cells, including
CC       hematopoietic cell lines like myeloid, B-, and T-cell lineages.
CC   -!- DOMAIN: The PH domain mediates the binding to inositol
CC       polyphosphate and phosphoinositides, leading to its targeting to
CC       the plasma membrane. It is extended in the BTK kinase family by a
CC       region designated the TH (Tec homology) domain, which consists of
CC       about 80 residues preceding the SH3 domain.
CC   -!- DOMAIN: The SH3 domain is essential for its targeting to activated
CC       CD28 costimulatory molecule. {ECO:0000250}.
CC   -!- PTM: Following B-cell or T-cell receptors engagement, translocates
CC       to the plasma membrane where it gets phosphorylated at Tyr-519.
CC       Undergoes also tyrosine phosphorylation during platelet
CC       activation. {ECO:0000269|PubMed:12573241,
CC       ECO:0000269|PubMed:7526158, ECO:0000269|PubMed:9299487,
CC       ECO:0000269|PubMed:9652744}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. TEC subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- CAUTION: It is uncertain whether Met-1 is the initiator.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D29767; BAA06171.1; -; mRNA.
DR   EMBL; CH471069; EAW93055.1; -; Genomic_DNA.
DR   EMBL; BC101711; AAI01712.1; -; mRNA.
DR   EMBL; BC101713; AAI01714.1; -; mRNA.
DR   EMBL; BC143487; AAI43488.1; -; mRNA.
DR   CCDS; CCDS3481.1; -.
DR   PIR; I38268; I38268.
DR   PIR; I56997; I56997.
DR   RefSeq; NP_003206.2; NM_003215.2.
DR   UniGene; Hs.479670; -.
DR   PDB; 2LUL; NMR; -; A=1-154.
DR   PDBsum; 2LUL; -.
DR   ProteinModelPortal; P42680; -.
DR   SMR; P42680; -.
DR   BioGrid; 112865; 23.
DR   IntAct; P42680; 18.
DR   MINT; MINT-1498364; -.
DR   STRING; 9606.ENSP00000370912; -.
DR   BindingDB; P42680; -.
DR   ChEMBL; CHEMBL4246; -.
DR   GuidetoPHARMACOLOGY; 2238; -.
DR   iPTMnet; P42680; -.
DR   PhosphoSitePlus; P42680; -.
DR   BioMuta; TEC; -.
DR   DMDM; 158518392; -.
DR   EPD; P42680; -.
DR   MaxQB; P42680; -.
DR   PaxDb; P42680; -.
DR   PeptideAtlas; P42680; -.
DR   PRIDE; P42680; -.
DR   DNASU; 7006; -.
DR   Ensembl; ENST00000381501; ENSP00000370912; ENSG00000135605.
DR   GeneID; 7006; -.
DR   KEGG; hsa:7006; -.
DR   UCSC; uc003gxz.4; human.
DR   CTD; 7006; -.
DR   DisGeNET; 7006; -.
DR   GeneCards; TEC; -.
DR   HGNC; HGNC:11719; TEC.
DR   HPA; HPA005733; -.
DR   HPA; HPA024657; -.
DR   MalaCards; TEC; -.
DR   MIM; 600583; gene.
DR   neXtProt; NX_P42680; -.
DR   OpenTargets; ENSG00000135605; -.
DR   PharmGKB; PA36436; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000119011; -.
DR   HOGENOM; HOG000233859; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; P42680; -.
DR   KO; K07364; -.
DR   OMA; RNMNRSK; -.
DR   OrthoDB; EOG091G0D46; -.
DR   PhylomeDB; P42680; -.
DR   TreeFam; TF351634; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-1433557; Signaling by SCF-KIT.
DR   Reactome; R-HSA-2871809; FCERI mediated Ca+2 mobilization.
DR   Reactome; R-HSA-512988; Interleukin-3, 5 and GM-CSF signaling.
DR   SignaLink; P42680; -.
DR   SIGNOR; P42680; -.
DR   ChiTaRS; TEC; human.
DR   GeneWiki; TEC_(gene); -.
DR   GenomeRNAi; 7006; -.
DR   PRO; PR:P42680; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000135605; -.
DR   CleanEx; HS_TEC; -.
DR   ExpressionAtlas; P42680; baseline and differential.
DR   Genevisible; P42680; HS.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0005543; F:phospholipid binding; NAS:BHF-UCL.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IMP:BHF-UCL.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0010543; P:regulation of platelet activation; IDA:UniProtKB.
DR   GO; GO:0042246; P:tissue regeneration; IBA:GO_Central.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001562; Znf_Btk_motif.
DR   Pfam; PF00779; BTK; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00402; TECBTKDOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00107; BTK; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS51113; ZF_BTK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; ATP-binding; Cell membrane;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Immunity; Kinase; Lipid-binding; Membrane; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   SH2 domain; SH3 domain; Transferase; Tyrosine-protein kinase; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    631       Tyrosine-protein kinase Tec.
FT                                /FTId=PRO_0000088170.
FT   DOMAIN        4    111       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      179    239       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   DOMAIN      247    345       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      370    623       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ZN_FING     113    149       Btk-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00432}.
FT   NP_BIND     376    384       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    489    489       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   METAL       121    121       Zinc. {ECO:0000250}.
FT   METAL       132    132       Zinc. {ECO:0000250}.
FT   METAL       133    133       Zinc. {ECO:0000250}.
FT   METAL       143    143       Zinc. {ECO:0000250}.
FT   BINDING     398    398       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     206    206       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000269|PubMed:12573241}.
FT   MOD_RES     228    228       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     519    519       Phosphotyrosine; by autocatalysis, LYN
FT                                and JAK2. {ECO:0000244|PubMed:19690332}.
FT   VARIANT      44     44       R -> Q (in dbSNP:rs35374286).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041850.
FT   VARIANT     563    563       R -> K (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041851.
FT   CONFLICT    514    514       V -> F (in Ref. 1; BAA06171).
FT                                {ECO:0000305}.
FT   STRAND        3     14       {ECO:0000244|PDB:2LUL}.
FT   STRAND       19     21       {ECO:0000244|PDB:2LUL}.
FT   STRAND       26     41       {ECO:0000244|PDB:2LUL}.
FT   STRAND       45     47       {ECO:0000244|PDB:2LUL}.
FT   STRAND       53     55       {ECO:0000244|PDB:2LUL}.
FT   HELIX        56     58       {ECO:0000244|PDB:2LUL}.
FT   STRAND       61     64       {ECO:0000244|PDB:2LUL}.
FT   STRAND       69     71       {ECO:0000244|PDB:2LUL}.
FT   STRAND       74     76       {ECO:0000244|PDB:2LUL}.
FT   STRAND       78     83       {ECO:0000244|PDB:2LUL}.
FT   STRAND       88     92       {ECO:0000244|PDB:2LUL}.
FT   HELIX        96    110       {ECO:0000244|PDB:2LUL}.
FT   STRAND      118    120       {ECO:0000244|PDB:2LUL}.
FT   STRAND      132    134       {ECO:0000244|PDB:2LUL}.
FT   STRAND      143    145       {ECO:0000244|PDB:2LUL}.
SQ   SEQUENCE   631 AA;  73581 MW;  F55DECBF9916E1F9 CRC64;
     MNFNTILEEI LIKRSQQKKK TSPLNYKERL FVLTKSMLTY YEGRAEKKYR KGFIDVSKIK
     CVEIVKNDDG VIPCQNKYPF QVVHDANTLY IFAPSPQSRD LWVKKLKEEI KNNNNIMIKY
     HPKFWTDGSY QCCRQTEKLA PGCEKYNLFE SSIRKALPPA PETKKRRPPP PIPLEEEDNS
     EEIVVAMYDF QAAEGHDLRL ERGQEYLILE KNDVHWWRAR DKYGNEGYIP SNYVTGKKSN
     NLDQYEWYCR NMNRSKAEQL LRSEDKEGGF MVRDSSQPGL YTVSLYTKFG GEGSSGFRHY
     HIKETTTSPK KYYLAEKHAF GSIPEIIEYH KHNAAGLVTR LRYPVSVKGK NAPTTAGFSY
     EKWEINPSEL TFMRELGSGL FGVVRLGKWR AQYKVAIKAI REGAMCEEDF IEEAKVMMKL
     THPKLVQLYG VCTQQKPIYI VTEFMERGCL LNFLRQRQGH FSRDVLLSMC QDVCEGMEYL
     ERNSFIHRDL AARNCLVSEA GVVKVSDFGM ARYVLDDQYT SSSGAKFPVK WCPPEVFNYS
     RFSSKSDVWS FGVLMWEVFT EGRMPFEKYT NYEVVTMVTR GHRLYQPKLA SNYVYEVMLR
     CWQEKPEGRP SFEDLLRTID ELVECEETFG R
//
